We use cookies to improve your experience. By continuing to browse this site, you accept our cookie policy.×
Skip main navigation
Aging Health
Bioelectronics in Medicine
Biomarkers in Medicine
Breast Cancer Management
CNS Oncology
Colorectal Cancer
Concussion
Epigenomics
Future Cardiology
Future Medicine AI
Future Microbiology
Future Neurology
Future Oncology
Future Rare Diseases
Future Virology
Hepatic Oncology
HIV Therapy
Immunotherapy
International Journal of Endocrine Oncology
International Journal of Hematologic Oncology
Journal of 3D Printing in Medicine
Lung Cancer Management
Melanoma Management
Nanomedicine
Neurodegenerative Disease Management
Pain Management
Pediatric Health
Personalized Medicine
Pharmacogenomics
Regenerative Medicine

Ascorbic acid as a modulator of inflammatory response against Candida albicans

    Noala Vicensoto Moreira Milhan

    *Author for correspondence:

    E-mail Address: milhan.noala@gmail.com

    Department of Environmental Engineering & Sciences Applied in Oral Health Graduate Program, São Paulo State University (Unesp), Institute of Science & Technology, São José dos Campos, São Paulo, 12245-000, Brazil

    ,
    Aline da Graça Sampaio

    Department of Environmental Engineering & Sciences Applied in Oral Health Graduate Program, São Paulo State University (Unesp), Institute of Science & Technology, São José dos Campos, São Paulo, 12245-000, Brazil

    ,
    Cristiane Yumi Koga-Ito‡

    Department of Environmental Engineering & Sciences Applied in Oral Health Graduate Program, São Paulo State University (Unesp), Institute of Science & Technology, São José dos Campos, São Paulo, 12245-000, Brazil

    ‡Authors contributed equally

    Search for more papers by this author

    &
    Angela Bruzzaniti‡

    Department of Biomedical & Applied Sciences, Indiana University School of Dentistry, Indianapolis, IN 46202, USA

    ‡Authors contributed equally

    Search for more papers by this author

    Published Online:https://doi.org/10.2217/fmb-2023-0188

    Aim: To evaluate the behavior of oral keratinocytes in the presence of Vitamin C (Vit C) and its anti-inflammatory potential. Materials & methods: Oral keratinocytes were initially exposed to 0.1–2.5 mM of Vit C and the metabolic activity and cell migration were evaluated using MTS assay and Ibidi culture inserts, respectively. After, the cells were challenged with Candida albicans and inflammatory markers were analyzed by qPCR. Results: The treatment was not cytotoxic, and the highest concentrations increased the metabolic activity at 24 h. Vit C delayed the cell migration at 48 and 72 h. Interestingly, it downregulated the genes IL-8 and IL-1β. Conclusion: Vit C could be an interesting adjuvant to anti-fungal treatment due to its anti-inflammatory potential.

    Plain language summary

    Vitamin C, also known as ascorbic acid, is a vitamin commonly found in fruits and vegetables. It is popular for supporting our immune system, so is commonly taken as a supplement. We looked at the action of vitamin C on cells from the mouth and its potential to reduce inflammation in a fungal disease of the mouth – oral candidiasis. We showed that vitamin C is not toxic to cells of the mouth and may reduce inflammation in cells infected by the fungus. This suggests that vitamin C could be used as a complementary therapy for oral candidiasis.

    Graphical abstract

    Papers of special note have been highlighted as: • of interest; •• of considerable interest

    References

    • 1. Vila T, Sultan AS, Montelongo-Jauregui D, Jabra-Rizk MA. Oral candidiasis: a disease of opportunity. J. Fungi. 6(1), 1–28 (2020). • Interesting review about oral candidiasis.
    • 2. Singh A, Verma R, Murari A, Agrawal A. Oral candidiasis: an overview. J. Oral Maxillofac. Pathol. 18(Suppl. 1), S81–S85 (2014).
    • 3. Lewis MAO, Williams DW. Diagnosis and management of oral candidosis. Br. Dent. J. 223(9), 675–681 (2017).
    • 4. Costa-de-oliveira S, Rodrigues AG. Candida albicans antifungal resistance and tolerance in bloodstream infections: the triad yeast-host-antifungal. Microorganisms 8(2), 154 (2020).
    • 5. Fuentefria AM, Pippi B, Dalla Lana DF, Donato KK, de Andrade SF. Antifungals discovery: an insight into new strategies to combat antifungal resistance. Lett. Appl. Microbiol. 66(1), 2–13 (2018).
    • 6. Al-Niaimi F, Chiang NYZ. Topical Vitamin C and the Skin: Mechanisms of Action and Clinical Applications. J. Clin. Aesthet. Dermatol. 10(7), 14–17 (2017).
    • 7. Van Hauwenhuyse F, Fiori A, Van Dijck P. Ascorbic acid inhibition of candida albicans Hsp90-mediated morphogenesis occurs via the transcriptional regulator Upc2. Eukaryot Cell 13(10), 1278–1289 (2014). •• This study investigated Vitamin C mechanisms of action on Candida albicans strains.
    • 8. Ojha R, Manzoor N, Khan LA. Ascorbic acid modulates pathogenecity markers of Candida albicans. Int. J. Microbiol. Res. 1(1), 19–24 (2009). •• Interesting manuscript about Vitamin C modulatory effects on Candida albicans strains.
    • 9. Avci P, Freire F, Banvolgyi A, Mylonakis E, Wikonkal NM, Hamblin MR. Sodium ascorbate kills Candida albicans in vitro via iron-catalyzed Fenton reaction: importance of oxygenation and metabolism. Future Microbiol. 11(12), 1535–1547 (2016). •• Indicated that ascorbate may present antimicrobial effects against Candida albicans strains.
    • 10. Lee AJ, Lim JW, Kim H. Ascorbic acid suppresses house dust mite-induced expression of interleukin-8 in human respiratory epithelial cells. J. Cancer Prev. 26(1), 64–70 (2021). •• Demonstrated in a different model of infection that vitamin C may present an anti-inflammatory effect.
    • 11. Mohammed Ahmed Yussif N, Abdul-Waniss Mohammed Abdul-Aziz M, Reda Abdel Rahman A. Evaluation of the anti-inflammatory effect of locally delivered vitamin C in the treatment of persistent gingival inflammation: clinical and histopathological study. J. Nutr. Metab. 2016, 2978741 (2016).
    • 12. Jablonská E, Kubásek J, Vojtěch D, Ruml T, Lipov J. Test conditions can significantly affect the results of in vitro cytotoxicity testing of degradable metallic biomaterials. Sci. Rep. 11, 6628 (2021).
    • 13. da Sampaio AG, Chiappim W, Milhan NVM, Botan Neto B, Pessoa R, Koga-Ito CY. Effect of the pH on the antibacterial potential and cytotoxicity of different plasma-activated liquids. Int. J. Mol. Sci. 23(22), 13893 (2022).
    • 14. Suarez-Arnedo A, Torres Figueroa F, Clavijo C, Arbeláez P, Cruz JC, Muñoz-Camargo C. An image J plugin for the high throughput image analysis of in vitro scratch wound healing assays. PLOS ONE 15(7), e0232565 (2020).
    • 15. Vitale RG. Role of antifungal combinations in difficult to treat candida infections. J. Fungi. 7(9), 731 (2021).
    • 16. Böttger F, Vallés-Martí A, Cahn L, Jimenez CR. High-dose intravenous vitamin C, a promising multi-targeting agent in the treatment of cancer. J. Exp. Clin. Cancer Res. 40(1), 343 (2021).
    • 17. Zylinska L, Lisek M, Guo F, Boczek T. Vitamin C modes of action in calcium-involved signaling in the brain. Antioxidants 12(2), 231 (2023).
    • 18. Aytekin Z, Arabacı T, Toraman A, Bayır Y, Albayrak M, Üstün K. Immune modulatory and antioxidant effects of locally administrated vitamin C in experimental periodontitis in rats. Acta Odontol. Scand. 78(6), 425–432 (2020).
    • 19. Lu SY. Oral candidosis: pathophysiology and best practice for diagnosis, classification, and successful management. J. Fungi 7(7), 555 (2021).
    • 20. Tsukaguchi H, Tokui T, Mackenzie B et al. A family of mammalian Na+-dependent L-ascorbic acid transporters. Nature 399(6731), 70–75 (1999).
    • 21. Ghahremani-Nasab M, Del Bakhshayesh AR, Akbari-Gharalari N, Mehdipour A. Biomolecular and cellular effects in skin wound healing: the association between ascorbic acid and hypoxia-induced factor. J. Biol. Eng. 17(1), 62 (2023).
    • 22. Cho S, Chae JS, Shin H et al. Hormetic dose response to L-ascorbic acid as an anti-cancer drug in colorectal cancer cell lines according to SVCT-2 expression. Sci. Rep. 8(1), 11372 (2018).
    • 23. Castellano-Pellicena I, Thornton MJ. Isolation of epidermal keratinocytes from human skin: the scratch-wound assay for assessment of epidermal keratinocyte migration. Methods Mol. Biol. 2154, 1–12 (2020).
    • 24. Chong WT, Tan CP, Cheah YK, Lai OM. In-vitro and in-vivo evaluations of tocotrienol-rich nanoemulsified system on skin wound healing. PLOS ONE 17(5), e0267381 (2022).
    • 25. Chaitrakoonthong T, Ampornaramveth R, Kamolratanakul P. Rinsing with L-ascorbic acid exhibits concentration-dependent effects on human gingival fibroblast in vitro wound healing behavior. Int. J. Dent. 2020, 4706418 (2020).
    • 26. Yi Y, Wu M, Zhou X et al. Ascorbic acid 2-glucoside preconditioning enhances the ability of bone marrow mesenchymal stem cells in promoting wound healing. Stem Cell Res. Ther. 13(1), 119 (2022).
    • 27. Savini I, Rossi A, Duranti G, Avigliano L, Catani MV, Melino G. Characterization of keratinocyte differentiation induced by ascorbic acid: protein kinase C involvement and vitamin C. J. Invest. Dermatol. 118(2), 372–379 (2002).
    • 28. Egusa H, Nikawa H, Makihira S, Yatani H, Hamada T. In vitro mechanisms of interleukin-8-mediated responses of human gingival epithelial cells to Candida albicans infection. Int. J. Med. Microbiol. 296(4–5), 301–311 (2006).
    • 29. Dongari-Bagtzoglou A, Kashleva H. Granulocyte-macrophage colony-stimulating factor responses of oral epithelial cells to Candida albicans. Oral Microbiol. Immunol. 18(3), 165–170 (2003).
    • 30. Griffiths JS, Camilli G, Kotowicz NK, Ho J, Richardson JP, Naglik JR. Role for IL-1 family cytokines in fungal infections. Front Microbiol. 12, 633047 (2021).
    • 31. Gao Y, Liang G, Wang Q et al. Different host immunological response to C. albicans by human oral and vaginal epithelial cells. Mycopathologia 184(1), 1–12 (2019).
    • 32. Kang JS, Kim HN, Jung DJ et al. Regulation of UVB-induced IL-8 and MCP-1 production in skin keratinocytes by increasing vitamin C uptake via the redistribution of SVCT-1 from the cytosol to the membrane. J. Invest. Dermatol. 127(3), 698–706 (2007).
    • 33. Bowie AG, O'Neill LAJ. Vitamin C inhibits NF-κB activation by TNF via the activation of p38 mitogen-activated protein kinase. J. Immunol. 165(12), 7180–7188 (2000).
    • 34. Gęgotek A, Skrzydlewska E. Antioxidative and anti-inflammatory activity of ascorbic acid. Antioxidants 11(10), 1993 (2022).
    • 35. Ghalibaf MHE, Kianian F, Beigoli S et al. The effects of vitamin C on respiratory, allergic and immunological diseases: an experimental and clinical-based review. Inflammopharmacology 31(2), 653–672 (2023).
    • 36. Cárcamo JM, Bórquez-Ojeda O, Golde DW. Vitamin C inhibits granulocyte macrophage-colony-stimulating factor-induced signaling pathways. Blood 99(9), 3205–3212 (2002).
    • 37. Chen Y, Luo G, Yuan J et al. Vitamin C Mitigates Oxidative Stress and Tumor Necrosis Factor-Alpha in Severe Community-Acquired Pneumonia and LPS-Induced Macrophages. Mediators Inflamm. 2014, 426740 (2014). •• In this study, a different model of infection was performed, in which vitamin C showed anti-inflammatory effect.
    • 38. Ness T, Abdallah M, Adams J et al. Candida albicans-derived mannoproteins activate NF-κB in reporter cells expressing TLR4, MD2 and CD14. PLOS ONE 12(12), e0189939 (2017).
    • 39. Lopes JP, Lionakis MS. Pathogenesis and virulence of Candida albicans. Virulence 13(1), 89–121 (2022).